-+ 0.00%
-+ 0.00%
-+ 0.00%

TEVA HIGHLIGHTS NEW REAL-WORLD DATA SHOWING UZEDY® (RISPERIDONE) OUTPERFORMS OTHER LONG-ACTING INJECTABLES IN KEEPING SCHIZOPHRENIA PATIENTS ON TREATMENT, WHILE REDUCING EMERGENCY CARE AND HEALTHCARE COSTS

Reuters·09/18/2026 20:31:00

Please log in to view news